Cell-Specific Proteomic Analysis in Caenorhabditis elegans by Yuet, Kai P. et al.
Cell-specific proteomic analysis in
Caenorhabditis elegans
Kai P. Yueta, Meenakshi K. Domab,c, John T. Ngoa,1, Michael J. Sweredoskid, Robert L. J. Grahamd,2, Annie Moradiand,
Sonja Hessd, Erin M. Schumane, Paul W. Sternbergb,c, and David A. Tirrella,3
Divisions of aChemistry and Chemical Engineering and bBiology and Biological Engineering, cHoward Hughes Medical Institute, and dProteome Exploration
Laboratory, Beckman Institute, California Institute of Technology, Pasadena, CA 91125; and eMax Planck Institute for Brain Research, D-60528 Frankfurt am
Main, Germany
Edited by Carolyn R. Bertozzi, University of California, Berkeley, CA, and approved January 22, 2015 (received for review November 10, 2014)
Proteomic analysis of rare cells in heterogeneous environments
presents difficult challenges. Systematic methods are needed to
enrich, identify, and quantify proteins expressed in specific cells
in complex biological systems including multicellular plants and
animals. Here, we have engineered a Caenorhabditis elegans phe-
nylalanyl-tRNA synthetase capable of tagging proteins with the
reactive noncanonical amino acid p-azido-L-phenylalanine. We
achieved spatiotemporal selectivity in the labeling of C. elegans
proteins by controlling expression of the mutant synthetase using
cell-selective (body wall muscles, intestinal epithelial cells, neu-
rons, and pharyngeal muscle) or state-selective (heat-shock) promoters
in several transgenic lines. Tagged proteins are distinguished from
the rest of the protein pool through bioorthogonal conjugation
of the azide side chain to probes that permit visualization and
isolation of labeled proteins. By coupling our methodology with
stable-isotope labeling of amino acids in cell culture (SILAC), we
successfully profiled proteins expressed in pharyngeal muscle
cells, and in the process, identified proteins not previously
known to be expressed in these cells. Our results show that tag-
ging proteins with spatiotemporal selectivity can be achieved in
C. elegans and illustrate a convenient and effective approach for
unbiased discovery of proteins expressed in targeted subsets
of cells.
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In a complex eukaryote like Caenorhabditis elegans, cell het-erogeneity restricts the usefulness of large-scale, mass spec-
trometry-based proteomic analysis. Enriching for specific cells
is challenging, and researchers cannot systematically identify
low-abundance proteins expressed in specific cells from whole-
organism lysates. Cell-selective bioorthogonal noncanonical amino
acid tagging (cell-selective BONCAT) offers a way to overcome
these limitations (1, 2). We have previously engineered a family of
mutant Escherichia coli methionyl-tRNA synthetases (MetRSs)
capable of appending the azide-bearing L-methionine (Met) ana-
log L-azidonorleucine (Anl) to its cognate tRNA in competition
with Met (3, 4). Because Anl is a poor substrate for any of the
natural aminoacyl-tRNA synthetases, it is excluded from proteins
made in wild-type cells but is incorporated readily into proteins
made in cells that express an appropriately engineered MetRS.
Controlling expression of mutant MetRSs by expression only in
specific cells restricts Anl labeling to proteins produced in those
cells. Tagged proteins can be distinguished from the rest of the
protein pool through bioorthogonal conjugation of the azide
side chain to alkynyl or cyclooctynyl probes that permit facile
detection, isolation, and visualization of labeled proteins. This
strategy has been used to selectively enrich microbial proteins
from mixtures of bacterial and mammalian cells. For example,
Ngo et al. (5) found that proteins made in an E. coli strain
outfitted with a mutant MetRS could be labeled with Anl
in coculture with murine alveolar macrophages, which were
not labeled. Using similar approaches, Grammel et al. (6)
identified virulence factors from Salmonella typhimurium that
were expressed in the course of infection of murine macro-
phages, and Mahdavi et al. (7) profiled Yersinia enterocolitica
proteins that were injected into HeLa cells. In a complementary
approach, Chin and coworkers (8) recently reengineered or-
thogonal Methanosarcina barkeri and Methanosarcina mazei
pyrrolysyl-tRNA synthetase/tRNA pairs for codon-selective in-
corporation of a cyclopropene lysine derivative into proteins
made in E. coli, Drosophila melanogaster ovaries, and HEK293
cells; however, this technique requires the expression of both
exogenous aminoacyl-tRNA synthetases and tRNAs. Here, we
configure cell-selective BONCAT for cell-specific proteomic
analysis in the nematode C. elegans (Fig. 1A). We first dem-
onstrate that restricted expression of a mutant C. elegans
phenylalanyl-tRNA synthetase (CePheRS) can label proteins
with p-azido-L-phenylalanine (Azf; Fig. 1B) with spatiotem-
poral selectivity in the live worm. We then show that cell-se-
lective BONCAT combined with stable-isotope labeling of
amino acids in cell culture (SILAC) provides a convenient and
effective approach for unbiased discovery of proteins uniquely
expressed in a subset of cells.
Significance
The emergence of mass spectrometry-based proteomics has
revolutionized the study of proteins and their abundances,
functions, interactions, and modifications. However, it is diffi-
cult to monitor dynamic changes in protein synthesis in a spe-
cific cell type within its native environment. Here we describe
a method that enables the metabolic labeling, purification, and
analysis of proteins in specific cell types and during defined
periods in live animals. Using Caenorhabditis elegans, we show
that labeling can be restricted to body wall muscles, intestinal
epithelial cells, neurons, pharyngeal muscle, and cells that respond
to heat shock. By coupling our methodology with isotopic label-
ing, we successfully identify proteins—including proteins with pre-
viously unknown expression patterns—expressed in targeted
subsets of cells.
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Engineering a C. elegans PheRS Capable of Activating Azf. We fo-
cused our attention on the heterotetrameric CePheRS because
we could not prepare healthy transgenic C. elegans strains that
express mutant E. coli MetRSs. Furthermore, we found that
C. elegans variants of the mutant E. coli MetRSs that we had
used to activate Anl in our previous experiments showed no
activity toward Anl (SI Appendix, Table S1). CePheRS catalyzes
esterification of L-phenylalanine (Phe; Fig. 1B) to its cognate
tRNA (CetRNAPhe) to form phenylalanyl-tRNA. A conserved
“gatekeeper” threonine (Thr412 [the first methionine in the al-
pha subunit of CePheRS, isoform A, exon 3 is designated as
residue 1 (“Met1”)], C. elegans numbering; Fig. 2A and SI Ap-
pendix, Fig. S1) in the alpha subunit has been proposed to play
a key role in determining substrate specificity in both prokaryotic
and eukaryotic PheRSs (9, 10). Therefore, we hypothesized that
mutating this residue to smaller residues should enable CePheRS
to activate and charge the larger azide-bearing Phe analog Azf to
CetRNAPhe. To screen for such an enzyme, we cultured KY14
[pKPY93/pKPY1XX], a phenylalanine-auxotrophic strain of E. coli
that expresses mutant forms of CePheRS, in M9 minimal medium
supplemented with different concentrations of Phe and Azf (Fig.
2B). To assess CePheRS activity toward Azf, we detected Azf-
labeled proteins by conjugation to dibenzocyclooctyne-func-
tionalized tetramethylrhodamine (TAMRA-DBCO; Fig. 1B)
and subsequent SDS/PAGE–in-gel fluorescence scanning. Although
Fig. 1. Cell-selective BONCAT analysis in C. elegans. (A) A mutant C. elegans
PheRS is capable of tagging proteins with the reactive noncanonical amino
acid Azf. Spatiotemporal selectivity is achieved by controlling expression of
the mutant synthetase using cell-selective promoters in transgenic lines.
Proteins synthesized in cells that do not express the synthetase are neither la-
beled nor detected. (B) Structures of amino acids and probes used in this study:
L-phenylalanine (Phe), p-azido-L-phenylalanine (Azf), dibenzocyclooctyne-func-
tionalized tetramethylrhodamine (TAMRA-DBCO), and sodium dithionite-
cleavable dibenzocyclooctyne-functionalized biotin (Diazo Biotin-DBCO).
Fig. 2. (A) Active site of eukaryotic PheRS with bound Phe (based on PDB ID
code 3L4G). (B) To screen for a mutant CePheRS that activates Azf, we used
KY14[pKPY93/pKPY1XX], a phenylalanine-auxotrophic strain of E. coli. This
strain houses two compatible plasmids: (i) pKPY93 encodes CetRNAPhe under
constitutive E. coli murein lipoprotein (lpp) promoter control and IPTG-
inducible (PT5) 6xHis-tagged GFP and (ii) pKPY1XX encodes both CePheRS
alpha and beta subunits under arabinose-inducible (PBAD) control.
(C ) SDS/PAGE and in-gel fluorescence scanning detection of strain-promoted
conjugation of TAMRA-DBCO to Azf-labeled proteins derived from
KY14[pKPY93/pKPY1XX] lysates. (D) We fed KY14[pKPY514] to hsp-
16.2::Thr412Gly-CePheRS animals. This E. coli strain harbors pKPY514, a
plasmid encoding Thr251Gly-EcPheRS under IPTG-inducible (PT5) control. hsp-
16.2::Thr412Gly-CePheRS C. elegans express both the mutant alpha subunit
and GFP under control of the hsp-16.2 promoter. (E) In-gel fluorescence scanning
of TAMRA-DBCO–treated lysates (Left) and fluorescence microscopy of TAMRA-
DBCO–treated fixed animals (Right) showed that only heat-shocked worms
exhibited ubiquitous Azf labeling 24 h after heat shock. (Scale bars: 100 μm.)
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several mutants (Thr412Ser, Thr412Ala, Thr412Gly) showed
evidence of labeling with Azf, only the Thr412Gly mutant
(Thr412Gly-CePheRS) displayed robust labeling in cells treated
with equimolar amounts of Phe and Azf (Fig. 2C). We confirmed
by in vitro ATP-PPi exchange assays that Thr412Gly-CePheRS is
highly selective toward Azf: it activates Azf more than 20-fold
faster than its canonical substrate Phe (SI Appendix, Table S2).
Thus, Azf labeling does not require depletion of Phe from an
animal’s diet, making cell-selective labeling feasible in live
worms. Although Thr412Gly-CePheRS also activates tryptophan
threefold faster than Phe, MALDI-TOF mass spectrometry
measurements of tryptic GFP peptides did not detect mis-
incorporation of tryptophan or any other canonical amino acid
when GFP was expressed in media supplemented with either Phe
or Azf (SI Appendix, Fig. S2). Collectively, these results suggest
that Thr412Gly-CePheRS selectively activates Azf with catalytic
efficiency similar to that observed in the activation of Phe by
wild-type CePheRS. Introducing the Thr412Gly mutation into
PheRSs of other eukaryotic cells including human also per-
mits Azf activation (SI Appendix, Fig. S3). From these obser-
vations, we conclude that Thr412Gly-CePheRS is the best
aminoacyl-tRNA synthetase candidate for cell-selective labeling in
C. elegans. Although we generated transgenic C. elegans by DNA
injection into the syncytial germ line in this work, inducible or cell-
selective genome editing technologies could be used to quickly
and efficiently generate transgenic animals because a single mu-
tation in CePheRS is sufficient for Azf activity (11).
Characterizing Azf Labeling in C. elegans. To evaluate the perfor-
mance of Thr412Gly-CePheRS in C. elegans, we first generated
transgenic C. elegans lines that express both the mutant alpha
subunit and GFP under control of the hsp-16.2 promoter (Fig.
2D). hsp-16.2 encodes a 16-kDa protein that is induced in mul-
tiple tissues in response to heat shock and other stresses (12).
Upon heat shock, we expected that the mutant alpha subunit
would be expressed and form a hybrid heterotetramer with the
endogenous beta subunit to produce fully active Thr412Gly-
CePheRS. In our initial feeding experiments, we did not detect
strong Azf labeling in transgenic animals when Azf was added
exogenously to either liquid culture or solid agar plates. How-
ever, we found that these lines could be labeled by replacing
their normal food source (e.g., E. coli OP50) with bacteria whose
proteins contain the noncanonical amino acid of choice in a
fashion analogous to isotopic labeling (13–15). We first labeled
bacteria by culturing KY14[pKPY514], a phenylalanine-auxo-
trophic strain of E. coli that expresses the E. coli variant of
Thr412Gly-CePheRS (Thr251Gly-EcPheRS), in M9 minimal
medium supplemented with Azf (SI Appendix, Fig. S4). The ex-
tent of replacement of Phe by Azf in total E. coli protein was
determined by amino acid analysis to be ∼50% (SI Appendix,
Fig. S5). We next fed labeled bacteria to hsp-16.2::Thr412Gly-
CePheRS worms previously grown on OP50. We induced heat
shock in worms grown at 20 °C by 1-h exposure to 33 °C and
cleared external as well as ingested bacteria by washing worms
with S medium over a period of 30 min. We could not detect
E. coli protein (even the overexpressed Thr251Gly-EcPheRS) in
processed C. elegans lysate (SI Appendix, Fig. S6). Both in-gel
fluorescence scanning of TAMRA–DBCO-treated lysates and
fluorescence microscopy of TAMRA–DBCO-treated fixed ani-
mals revealed that only heat-shocked worms exhibited ubiqui-
tous Azf labeling 24 h after heat shock (Fig. 2E). We detected
labeled proteins as early as 1 h after heat shock (shorter times
were not tested). Moreover, we observed no differences in be-
havior, development, or survival in worms fed with Azf-labeled
E. coli versus worms fed with unlabeled E. coli for up to 72 h
after heat shock (longer times were not tested).
Labeling Spatially Defined Protein Subpopulations. The core con-
cept of cell-selective BONCAT is that restricting expression of
mutant aminoacyl-tRNA synthetases by using promoters active
only in specific cells restricts noncanonical amino acid labeling
to those cells. Enrichment of labeled proteins permits examina-
tion of proteomic changes in those cells. Encouraged by the
performance of hsp-16.2::Thr412Gly-CePheRS worms, we next
tested cell-specific expression of Thr412Gly-CePheRS by gen-
erating transgenic C. elegans lines that express both the mutant
alpha subunit and GFP under control of promoters shown pre-
viously to be active specifically in the 95 body wall muscle cells
(myo-3; ref. 16), the 20 intestinal cells (ges-1; ref. 17), neurons
(rab-3; ref. 18), and the 20 pharyngeal muscle cells (myo-2;
ref. 19) (Fig. 3A). We first fed Azf-labeled bacteria to each of
these animals. We also observed no differences in behavior, de-
velopment, or survival in worms fed with Azf-labeled E. coli
versus worms fed with unlabeled E. coli for up to 72 h (longer
times were not tested). We then treated fixed worms with
TAMRA-DBCO to visualize sites of Azf incorporation. Fluo-
rescence microscopy revealed that labeling in myo-3::Thr412Gly-
CePheRS, ges-1::Thr412Gly-CePheRS, rab-3::Thr412Gly-CePheRS,
and myo-2::Thr412Gly-CePheRS worms was confined to the body
wall muscle, intestine, neurons, and pharyngeal muscle, respectively
(Fig. 3B and SI Appendix, Figs. S7 and S8).
Identifying Pharyngeal Muscle-Specific Proteins. We next investi-
gated whether proteins isolated from worms with cell-specific
Thr412Gly-CePheRS fit characteristics of the targeted cell
type. We were particularly interested in the C. elegans pharynx,
a widely used model to study organ formation during em-
bryogenesis (20). The pharynx is a tube-like muscular pump
that concentrates, grinds, and transports bacteria from the
mouth to the intestine and comprises 68 cells: 9 epithelial,
4 gland, 9 marginal, 20 muscle, 20 neuronal, and 6 valve cells. We
aimed to identify proteins expressed in pharyngeal muscle cells
of myo-2::Thr412Gly-CePheRS worms by using a combined cell-
selective BONCAT and SILAC approach. We first triply labeled
food by culturing KY33[pKPY514], an arginine-, lysine-, and
phenylalanine-auxotrophic strain of E. coli, in M9 minimal me-







16O2), and Azf. We next fed these
bacteria to fourth larval stage myo-2::Thr412Gly-CePheRS ani-
mals previously grown on “light” OP50. According to our model
of the cell-selective BONCAT method, all newly synthesized
proteins in the animal should contain both heavy arginine and
heavy lysine, but only newly synthesized proteins made in pharyn-
geal muscle cells—the cells that express Thr412Gly-CePheRS—
should contain Azf. This model gives rise to four classes of pro-
teins: (i) light preexisting proteins synthesized in pharyngeal
muscle cells before the shift in food source, (ii) light preexisting
proteins synthesized in nontargeted cell types, (iii) heavy newly
synthesized proteins—labeled with Azf—made in pharyngeal
muscle cells after the shift in food source, and (iv) heavy newly
synthesized proteins made in nontargeted cell types. The use of
heavy labels enables relative quantitation of newly synthesized
(heavy, H) and preexisting (light, L) peptides. Because enrich-
ment concentrates heavy peptides derived from Azf-labeled pro-
teins, cell selectivity can be quantified by comparing H/L
ratios for “enriched” and “unenriched” proteins derived from
the same worm sample. Proteins with the highest values of
(H/L)E/(H/L)U should have originated from pharyngeal muscle
cells. Following 24 h of labeling through feeding, worm lysates were
incubated with sodium dithionite-cleavable dibenzocyclooctyne-
functionalized biotin (Diazo Biotin-DBCO; Fig. 1B), and Azf-
containing proteins were isolated by streptavidin affinity chroma-
tography (Fig. 3C and SI Appendix, Figs. S9–S11). Enriched and
unenriched samples were resolved by SDS/PAGE and subjected to








in-gel proteolytic digestion and liquid chromatography-tandem
mass spectrometry (LC-MS/MS) analysis.
We identified and quantified 2,270 proteins across triplicate
paired (enriched and unenriched) experiments (Fig. 3D and SI
Appendix, Figs. S12 and 13 and Table S3). Of the quantified
proteins, 1,607 (71%) had (H/L)E/(H/L)U values greater than
one, which indicates that the purification method successfully
enriched newly synthesized, cell-specific proteins. Among the
enriched proteins were 782 proteins that have expression patterns
reported in the literature according to WormBase WS244 (21);
of these proteins, 409 are known to be expressed in the pharynx
(SI Appendix, Table S4). We expected that proteins expressed
in pharyngeal muscle cells would be overrepresented among
proteins with high (H/L)E/(H/L)U values and, indeed, found that
of the top 12 proteins quantified, two [TNI-4 (22), a troponin
I protein and TNC-2 (23), a troponin C protein] are expressed
exclusively in pharyngeal muscle cells. Two proteins [SHL-1 (24),
a voltage-gated potassium channel and NCX-2 (25), a sodium-
calcium exchanger] are expressed in many muscle cells including
pharyngeal muscle cells. A fifth protein F59F4.1 (26) is an acyl-
CoA oxidase that is also expressed in the pharynx. Also, three
well-known pharyngeal muscle-specific myosin heavy chains were
among the top 3% of most highly enriched proteins: MYO-1
(top 1.0%, 22/2,270), MYO-2 (top 1.3%, 29/2,270), and MYO-5
(top 2.6%, 58/2,270). Although the right tail of the (H/L)E/(H/L)U
distribution contains relatively few members, they represent
pharynx-specific proteins: of the 1,100 proteins in our dataset
with known expression patterns, 7 of the 18 that are thought to
be expressed exclusively in the pharynx have (H/L)E/(H/L)U
values greater than two (P = 1.25 × 10−8; Fisher’s exact test).
When we examined a test set of 34 proteins whose genes are
highly expressed in body wall muscle, intestinal epithelia, and
neuronal cells (27), we found only three in our dataset (SI Ap-
pendix, Table S5). Two of the three are also expressed in the
pharynx (28, 29). Although the absence of a protein from
a proteomic dataset cannot be taken as evidence that the pro-
tein is absent from the sample, this result is consistent with the
hypothesis that the method described here provides an effective
means of enriching pharyngeal proteins.
Three of the remaining seven “top-12” proteins in our dataset
(C53C9.2, K03E5.2, and CPN-4) share similarity with Calponin-1
(30), a human protein implicated in the regulation of smooth
muscle contraction, but their expression patterns have not been
reported. To determine whether they are expressed in pharyn-
geal muscle cells, we generated transgenic C. elegans lines that
express GFP under control of each of the respective 5′ regulatory
regions. We detected strong GFP fluorescence exclusively in pha-
ryngeal muscle cells in C53C9.2::gfp, K03E5.2::gfp and cpn-4::gfp
animals (Fig. 3E). Calponin-1 has a single calponin homology
(CH) and multiple calponin family repeat (CFR) domains. No-
tably, like its muscle-specific paralog CPN-3, CPN-4 has a CH
domain, but no CFRs (SI Appendix, Fig. S14). In contrast,
C53C9.2 and K03E5.2 have multiple CFRs but no CH domains.
Only four C. elegans proteins contain multiple CFRs: C53C9.2,
K03E5.2, T25F10.6, and UNC-87 (31), a protein required to
maintain structure of myofilaments in muscle cells. T25F10.6
(top 5.3%, 121/2,270) and UNC-87 (top 7.5%, 170/2,270) were
also among the top 10% of most highly enriched proteins. Al-
though the characterization of new pharyngeal proteins was be-
yond the scope of this work, their placement among highly
enriched proteins, localization, and similarity to other muscle-
specific proteins suggest that C53C9.2, K03E5.2, and CPN-4 are
excellent candidates for regulating aspects of pharyngeal muscle
biology. Together, these results demonstrate that the approach
described here can be used to identify proteins (including pro-
teins with previously unknown expression patterns) that are
expressed in targeted subsets of cells. We note that in a cell-
selective BONCAT experiment, proteins are labeled only after
the shift in food source. Although long labeling times can be
used to profile the majority of proteins in specific cells, short
Fig. 3. (A) We fed E. coli strain KY14[pKPY514] to myo-3::Thr412Gly-CePheRS,
ges-1::Thr412Gly-CePheRS, rab-3::Thr412Gly-CePheRS, and myo-2::Thr412Gly-
CePheRS animals. These transgenic C. elegans strains express both the mutant
PheRS alpha subunit and GFP under control of themyo-3, ges-1, rab-3, ormyo-2
promoters, respectively. (B) Fluorescence microscopy revealed that labeling
in myo-3::Thr412Gly-CePheRS (Left), ges-1::Thr412Gly-CePheRS (Center Left),
rab-3::Thr412Gly-CePheRS (Center Right) andmyo-2::Thr412Gly-CePheRS (Right)
worms was localized to body wall muscle, intestine, neurons, and pharyngeal
muscle, respectively; the surrounding tissues were not labeled. (C) Tagged
proteins were distinguished from other proteins through conjugation of the
azide side chain to probes that permit isolation of the labeled proteins. The
conjugation reaction is bioorthogonal, i.e., the reaction is rapid and selective for
labeled proteins and probes, and effectively inert with respect to other com-
ponents found in worms. Worm lysates were reacted with sodium dithionite-
cleavable Diazo Biotin-DBCO (i), and Azf-labeled proteins were isolated by
streptavidin affinity chromatography (ii). The structure of the biotin reagent
has been simplified; the full structure is shown in Fig. 1B. (D) LC-MS/MS analysis
of myo-2::Thr412Gly-CePheRS animals fed with triply labeled E. coli (heavy ar-
ginine, heavy lysine, and Azf) for 24 h. Solid blue diamond markers represent
proteins that are expressed exclusively in the pharynx. Open red circle markers
represent proteins that are expressed in the pharynx. Open black circle markers
represent proteins that have either unknown expression patterns or expression
patterns not associated with the pharynx. The proteins discussed in this work
are marked. (E) Fluorescence microscopy confirmed GFP fluorescence was ex-
clusively localized to pharyngeal muscle cells in C53C9.2::gfp (Left), K03E5.2::gfp
(Center) and cpn-4::gfp (Right) animals. (Scale bars: 100 μm.)
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labeling times can be used to capture rapid changes in protein
expression in those cells.
In summary, by using cell-specific promoters to drive expres-
sion of an engineered CePheRS, we demonstrated that cell-
selective BONCAT coupled with SILAC can be used to identify
proteins with spatiotemporal selectivity in living C. elegans. For
future experiments, we suggest several avenues for improvement.
First, we incubated worm lysates with Diazo Biotin-DBCO and
isolated Azf-labeled proteins by streptavidin affinity chroma-
tography. Because streptavidin affinity chromatography requires
mild washing conditions to preserve streptavidin’s bioactivity,
enrichment quality might be affected by background proteins
due to insufficient washing. Alternatively, Azf-labeled proteins
can be selectively captured on commercially available alkynyl- or
cyclooctynyl-functionalized resins that allow for highly stringent
washing conditions to remove nonspecifically bound proteins.
Second, we processed samples by SDS/PAGE and in-gel pro-
teolytic digestion before LC-MS/MS analysis, but this approach
can introduce contaminants and is time-consuming and labori-
ous. Because chemical tagging of Azf-labeled proteins occurs
immediately after animal lysis, our strategy is compatible with
new advances in analytical proteomic workflows such as in
StageTip-based filter-aided sample preparation (FASP) (32).
Third, in the LC-MS/MS analysis, we normalized H/L ratios of
enriched proteins to total unenriched proteins derived from the
same worm sample. Because the H/L ratio variability depends on
different intrinsic rates of protein synthesis in different cells,
we advise investigators to additionally normalize H/L ratios of
enriched proteins from one cell type to total proteins derived from
mixed-stage worms or enriched proteins from another cell type for
a more comprehensive analysis of cell-specific proteins.
Finally, our methodology should prove useful in multiple
contexts. For example, one could easily build cell-specific pro-
teomic atlases because (i) a catalog of cell-specific transcrip-
tional enhancers is readily available and (ii) the creation of
transgenic organisms is both rapid and routine. In addition, using
regulatory elements to drive intersectional patterns of expres-
sion, one could restrict labeling to cells that express both ele-
ments and, thus, enhance spatiotemporal selectivity with either
a FLP recombinase-based (33) or protein reconstitution-based
(34) approach. Furthermore, this technique could be used to
study protein–protein interactions in a cell-specific manner
because aryl azides like Azf are activated upon UV light irradi-
ation to form covalent adducts with proteins in close proximity
(35). In principle, the methodology described here could be
applied to other organisms in which efficient delivery of non-
canonical amino acids is feasible, alleviating the need for cell
sorting or laser capture techniques to isolate protein from spe-
cific cells in intact organisms.
Materials and Methods
Full details regarding experimental procedures can be found in SI Appendix,
SI Materials and Methods.
Labeling in C. elegans. C. elegans strains previously maintained in S medium
supplemented with 25 mg/mL E. coli OP50 at 20 °C with agitation were
pelleted by centrifugation at 1,000 × g for 5 min at room temperature,
washed three times with S medium and resuspended in S medium supple-
mented with 25 mg/mL E. coli KY14[pKPY514] or KY33[pKPY514]. Following
labeling, worms were harvested by centrifugation at 1,000 × g for 5 min at
room temperature and cleaned by sucrose flotation. Bacterial material was
cleared by washing worms with S Medium over a period of 30 min. Worms
were pelleted by centrifugation at 1,000 × g for 5 min at room temperature
and frozen in liquid nitrogen.
Labeling in E. coli. To prepare KY14[pKPY514] or KY33[pKPY514], overnight
cultures were diluted into freshly prepared M9 medium and agitated at 37 °C
until reaching an OD600 of 0.5. Cells were pelleted by centrifugation at 5,000 × g
for 15 min at 4 °C, washed three times with ice-cold 0.9% (wt/vol) sodium
chloride, and resuspended in freshly prepared M9 minimal medium (without
Phe) supplemented with 2.0 mM Azf. After another 30 min of agitation at
37 °C, expression of Thr251Gly-EcPheRS was induced by the addition of 1 M
IPTG. After 4 h of agitation at 37 °C, cells were harvested by centrifugation
at 5,000 × g for 15 min at 4 °C and resuspended in freshly prepared M9
minimal medium (without Phe) supplemented with 2.0 mM Azf at a con-
centration of 250 mg of wet cell mass/mL medium and stored at 4 °C.
ACKNOWLEDGMENTS. We thank past and present members of the P.W.S.
and D.A.T. laboratories for fruitful discussions and suggestions, and Roxana
Eggleston-Rangel and Geoffrey T. Smith (Proteome Exploration Laboratory,
Beckman Institute, California Institute of Technology) for technical assis-
tance. This work was supported by National Institutes of Health (NIH) Grant
R01 GM062523. K.P.Y. was supported in part by a National Science Foun-
dation graduate fellowship. P.W.S. is an Investigator of the Howard Hughes
Medical Institute, which supported this work. The Proteome Exploration
Laboratory is supported by Gordon and Betty Moore Foundation Grant
GBMF775, the Beckman Institute, and NIH Grant 1S10RR029594-01A1.
1. Ngo JT, Tirrell DA (2011) Noncanonical amino acids in the interrogation of cellular
protein synthesis. Acc Chem Res 44(9):677–685.
2. Yuet KP, Tirrell DA (2014) Chemical tools for temporally and spatially resolved mass
spectrometry-based proteomics. Ann Biomed Eng 42(2):299–311.
3. Link AJ, et al. (2006) Discovery of aminoacyl-tRNA synthetase activity through cell-
surface display of noncanonical amino acids. Proc Natl Acad Sci USA 103(27):10180–10185.
4. Tanrikulu IC, Schmitt E, Mechulam Y, Goddard WA, 3rd, Tirrell DA (2009) Discovery of
Escherichia coli methionyl-tRNA synthetase mutants for efficient labeling of proteins
with azidonorleucine in vivo. Proc Natl Acad Sci USA 106(36):15285–15290.
5. Ngo JT, et al. (2009) Cell-selective metabolic labeling of proteins. Nat Chem Biol 5(10):
715–717.
6. Grammel M, Zhang MM, Hang HC (2010) Orthogonal alkynyl amino acid reporter for
selective labeling of bacterial proteomes during infection. Angew Chem Int Ed Engl
49(34):5970–5974.
7. Mahdavi A, et al. (2014) Identification of secreted bacterial proteins by noncanonical
amino acid tagging. Proc Natl Acad Sci USA 111(1):433–438.
8. Elliott TS, et al. (2014) Proteome labeling and protein identification in specific tissues
and at specific developmental stages in an animal. Nat Biotechnol 32(5):465–472.
9. Mermershtain I, et al. (2011) Idiosyncrasy and identity in the prokaryotic Phe-system:
Crystal structure of E. coli phenylalanyl-tRNA synthetase complexed with phenylala-
nine and AMP. Protein Sci 20(1):160–167.
10. Finarov I, Moor N, Kessler N, Klipcan L, Safro MG (2010) Structure of human cytosolic
phenylalanyl-tRNA synthetase: Evidence for kingdom-specific design of the active
sites and tRNA binding patterns. Structure 18(3):343–353.
11. Shen Z, et al. (2014) Conditional knockouts generated by engineered CRISPR-Cas9
endonuclease reveal the roles of coronin in C. elegans neural development. Dev Cell
30(5):625–636.
12. Stringham EG, Dixon DK, Jones D, Candido EPM (1992) Temporal and spatial ex-
pression patterns of the small heat shock (hsp16) genes in transgenic Caenorhabditis
elegans. Mol Biol Cell 3(2):221–233.
13. Krijgsveld J, et al. (2003) Metabolic labeling of C. elegans and D. melanogaster for
quantitative proteomics. Nat Biotechnol 21(8):927–931.
14. Fredens J, et al. (2011) Quantitative proteomics by amino acid labeling in C. elegans.
Nat Methods 8(10):845–847.
15. Larance M, et al. (2011) Stable-isotope labeling with amino acids in nematodes. Nat
Methods 8(10):849–851.
16. Miller DM, Ortiz I, Berliner GC, Epstein HF (1983) Differential localization of two
myosins within nematode thick filaments. Cell 34(2):477–490.
17. Egan CR, et al. (1995) A gut-to-pharynx/tail switch in embryonic expression of the Cae-
norhabditis elegans ges-1 gene centers on two GATA sequences.Dev Biol 170(2):397–419.
18. Nonet ML, et al. (1997) Caenorhabditis elegans rab-3 mutant synapses exhibit im-
paired function and are partially depleted of vesicles. J Neurosci 17(21):8061–8073.
19. Ardizzi JP, Epstein HF (1987) Immunochemical localization of myosin heavy chain
isoforms and paramyosin in developmentally and structurally diverse muscle cell types
of the nematode Caenorhabditis elegans. J Cell Biol 105(6 Pt 1):2763–2770.
20. Mango SE (2007) The C. elegans pharynx: A model for organogenesis. WormBook,
10.1895/wormbook.1.129.1.
21. (2014) WormBase, Release WS244. Available at www.wormbase.org. Accessed
November 10, 2014.
22. Ruksana R, et al. (2005) Tissue expression of four troponin I genes and their molecular
interactions with two troponin C isoforms in Caenorhabditis elegans. Genes Cells
10(3):261–276.
23. Kagawa H, Adachi R (2005) Summary of spaceflight of mutant animal in the first
international Caenorhabditis elegans experiment: ICE-first. Biol Sci Space 19:74–75.
24. Fawcett GL, et al. (2006) Mutant analysis of the Shal (Kv4) voltage-gated fast transient
K+ channel in Caenorhabditis elegans. J Biol Chem 281(41):30725–30735.
25. Sharma V, et al. (2013) Insight into the family of Na+/Ca2+ exchangers of Caeno-
rhabditis elegans. Genetics 195(2):611–619.
26. McKay SJ, et al. (2003) Gene expression profiling of cells, tissues, and developmental
stages of the nematode C. elegans. Cold Spring Harb Symp Quant Biol 68:159–169.








27. Gimona M, Kaverina I, Resch GP, Vignal E, Burgstaller G (2003) Calponin repeats
regulate actin filament stability and formation of podosomes in smooth muscle cells.
Mol Biol Cell 14(6):2482–2491.
28. Spencer WC, et al. (2011) A spatial and temporal map of C. elegans gene expression.
Genome Res 21(2):325–341.
29. Gu T, Orita S, Han M (1998) Caenorhabditis elegans SUR-5, a novel but conserved
protein, negatively regulates LET-60 Ras activity during vulval induction.Mol Cell Biol
18(8):4556–4564.
30. Chen C, Tuck S, Byström AS (2009) Defects in tRNA modification associated with
neurological and developmental dysfunctions in Caenorhabditis elegans elongator
mutants. PLoS Genet 5(7):e1000561.
31. Goetinck S, Waterston RH (1994) The Caenorhabditis elegans muscle-affecting gene unc-
87 encodes a novel thin filament-associated protein. J Cell Biol 127(1):79–93.
32. Kulak NA, Pichler G, Paron I, Nagaraj N, Mann M (2014) Minimal, encapsulated pro-
teomic-sample processing applied to copy-number estimation in eukaryotic cells. Nat
Methods 11(3):319–324.
33. Davis MW, Morton JJ, Carroll D, Jorgensen EM (2008) Gene activation using FLP re-
combinase in C. elegans. PLoS Genet 4(3):e1000028.
34. Mahdavi A, et al. (2013) A genetically encoded and gate for cell-targeted metabolic
labeling of proteins. J Am Chem Soc 135(8):2979–2982.
35. Fleet GWJ, Porter RR, Knowles JR (1969) Affinity labelling of antibodies with aryl
nitrene as reactive group. Nature 224:511–512.
2710 | www.pnas.org/cgi/doi/10.1073/pnas.1421567112 Yuet et al.
